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Abstract  
In epidemiologic analytical studies, the primary goal is to obtain a valid and precise estimate of the effect of the exposure 
of interest on a given outcome in the population under study. A crucial source of violation of the internal validity of a 
study involves bias arising from confounding, which is always a challenge in observational research, including life course 
epidemiology. The increasingly popular approach of meta-analyzing individual participant data from several 
observational studies also brings up to discussion the problem of confounding when combining data from different 
populations. In this study, we review and discuss the most common sources of confounding in life course epidemiology: 
(i) confounding by indication, (ii) impact of baseline selection on confounding, (iii) time-varying confounding and (iv) 
mediator– outcome confounding. We also discuss the issue of addressing confounding in the context of an individual 
participant data meta-analysis. 
 
 
Introduction 
 
 
Life course epidemiology seeks to understand the influence of several exposures across the life course, including in fetal 
life, on later health or disease risk.1 Large-scale birth cohort studies provide a unique opportunity to model early life 
exposures in relation to later life outcomes. The implementation of life course models presents many methodological 
challenges for both the design and analysis of epidemiological studies.2 The primary goal of an analytical epi-demiologic 
study is to obtain a valid and precise estimate of the effect of an exposure on an outcome. However, the internal validity 
of an estimate of a causal effect can be compromised by bias arising from confounding. Although confounding occurs in 
experimental research, it is a considerably more important issue in observational studies. Besides the general concept, 
some specific sources of confounding, including confounding by indication, confounding pattern altered by baseline 
selection, time-varying confounding and mediator–outcome con-founding, are worth discussing in the context of life 
course epidemiology. Moreover, in this context, it is becoming increasingly common to combine individual-level data 
from several birth cohort studies in a meta-analysis, which offers advantages over the traditional aggregate data meta-
analysis.3 However, it remains unclear how the confounding should be addressed when data from different studies are 
centrally analyzed.  
In this study, we first use directed acyclic graphs (DAGs) to briefly introduce the general concept of confounding. We 
then describe, provide examples and discuss specific sources of confounding that may play a relevant role in birth cohort 
studies: (i) confounding by indi-cation, (ii) impact of baseline selection on confounding, (iii) time-varying confounding 
and mediator–outcome confounding. Finally, we discuss the issue of addressing confounding in the context of individual 
participant data meta-analyses. 
 
Confounding 
 
Confounding may be referred to as a ‘mixing of effects’ in which the effect of the exposure of interest on a given outcome 
is mixed with the effects of other factors resulting in a distortion of the true effect.4 Confounding factors can overestimate 
or underestimate an effect, depending on the direction of their associations with exposure and outcome. The magnitude of 
confounding is of much greater importance than its mere presence or absence since it can hide a causal effect, falsely 
demonstrate an association where no causal association exists or even change the apparent direction of the effect estimate. 
Traditionally, for a variable to be a confounder, it must have three necessary (but not sufficient) characteristics: (1) it is a 
risk factor for the outcome conditional on the exposure; (2) it is associated with the exposure; and it is not affected by the 
exposure or the outcome, in particular, it cannot be an intermediate step in the causal path between the exposure and the 
outcome.4 Under the increasingly used graphical criteria, a confounder might be defined as a variable that should be used 
to block an otherwise open backdoor path. A backdoor path is a path from the exposure to the outcome that starts with an 
arrow pointing to the exposure. A collider is a variable which at least two arrows point to. A backdoor path is marginally 
blocked when contains a collider or is conditionally blocked when contains a non-collider on which it is conditioned 
(adjusted). Adjusting for a collider opens a path that was naturally blocked.4,5 Two potential scenarios are illustrated in 
Fig. 1, where E1 and E2 are the exposures of interest, Y the outcome and C a common cause of E1 and Y. The DAG in Fig. 
1 shows two backdoor paths from E1 to Y (E1–C–Y and E1–E2–Y), which are both marginally open (i.e., are not blocked 
before conditioning). Therefore, in order to estimate the effect of E1 on Y, the analysis should condition on C and E2. On 
the other hand, to estimate the effect of E2 on Y the analysis does not need to condition on C or E1 because there are no 
backdoor paths from E2 to Y (i.e., no paths from E2 to Y starting with an arrow pointing to E2).  
The traditional and graphical criteria for confounding usually lead to the same set of covariates for adjustment, and they 
both rely on external knowledge. For example, considering Fig. 1, both criteria indicate that C is a confounder of the 
effect of E1 on Y. However, there are cases in which the traditional and the DAGs criteria disagree, and when that 
happens, it is the traditional criteria that fail, assuming that the graphical approach depicts correctly the underlying causal 
relationships among variables. A classical example, the so-called M-diagram,5 is illustrated in Fig. 2, where E is the 
exposure, Y the outcome, U1 a common cause of E and C and U2 a common cause of C and Y. In this DAG, C meets the 
three traditional criteria for a confounder since C is related to E and Y (by sharing a cause, U1 and U2, respec-tively), and 
it is not affected by E or Y. Based on the assumed causal structure, there is a backdoor path from E to Y that is blocked at 
C since C is a collider. Thus, no adjustment for C should be made; if C is adjusted for, the path becomes open and could 
only be blocked by conditioning on either U1 or U2. In the absence of data on U1 and U2, adjustment for C would 
introduce bias where none was present and lead to a potential spurious association between E and Y. An example of such 
scenario is a study that aims to evaluate the effect of breastfeeding (E) on later child’s obesity (Y), where maternal 
education (U1) is related to both breastfeeding and maternal obesity (C) and mother’s genetic obesity risk (U2) is related 
to both maternal obesity and child’s obesity (assuming that maternal education does not affect child’s obesity). Under 
these circumstances, maternal obesity would be identified as a confounder based on the traditional criteria but as a 
collider based on the graphical criteria. This reinforces why the traditional criteria might fail under some circumstances: 
every confounder must satisfy the traditional criteria but some non-confounders satisfy them as well.4 
 
 
Specific sources of confounding  
Confounding by indication 
 
Confounding by indication is a potentially severe form of con-founding that arises when the indication for the treatment 
under study is a cause, or a consequence of a cause, of the outcome of interest.6,7 For example, stage could confound a 
study on treat-ment for a given disease and overall mortality, or history of gastric problems could confound a study on use 
of anti-inflammatory drugs and gastric ulcer.7 The latter example could also be labeled as confounding by 
contraindication.8  
In birth cohort research, confounding by indication may arise either for the child indication for the treatment or for 
maternal indication for the treatment during pregnancy or the peri-conceptional period. Figure 3a depicts a simple 
example of con-founding by indication occurring when the child prognostic or risk factors for the disease of interest affect 
his/her likelihood of receiving the treatment. For example, in studies on exposure to antibiotics in infancy and asthma or 
lung function at school age, infant respiratory infections induce exposure to antibiotics and may increase the risk of 
asthma later in life.9 To estimate the causal effect of antibiotics on asthma, it would be necessary to control for 
confounding by indication due to respiratory infec-tions. One option would be to simply adjust for respiratory infections 
and another option would be to consider only exposure to antibiotics used for non-respiratory infections, thus breaking at 
least in part the indication pathway. Several other analytical options and design approaches are available.10,11  
The mechanism inducing confounding by indication is slightly more complex when the study focuses on exposure to a 
maternal treatment in pregnancy and a child health outcome. There is confounding by indication if the maternal 
characteristics that induce the treatment are associated with the child prognostic or risk factors for the disease under study. 
This usually happens through a backdoor path (Fig. 3b). For example, in a study on maternal use of antibiotics during 
pregnancy and asthma at school age, maternal respiratory tract infections during pregnancy could act as confounders by 
indication. Maternal respiratory infections induce the use of antibiotics and may be associated with the risk of child 
asthma, assuming that the increased maternal susceptibility to respiratory infections is associated with a similar child 
increased susceptibility to respiratory infections or asthma – the shared transmitted susceptibility is thus the reason for the 
open backdoor path.12 In some instances, the maternal characteristics that induce the treatment directly affect child health, 
and the mechanism underlying confounding by indication becomes more similar to that depicted in Fig. 3a. For example, 
in a study of maternal use of antidepressant drugs in pregnancy and the risk of cardiac malformation, maternal conditions 
indicating for the use of antidepressants, including depression, sleep dis-orders, other mental health disorders, could cause 
cardiac mal-formations, for example, through their induced lifestyles (e.g., smoking). To control for confounding by 
indication in this sce-nario, in a large register-based study, analyses were restricted to mothers with a depression diagnosis 
and further stratified on a propensity score for the predicted probability of treatment.13  
In case of child indication for the treatment, the terminology confounding by indication might be incorrectly used to 
indicate reverse causation or protopathic bias,14 which occurs when the early manifestations of the outcome of interest 
induce the treat-ment.8,15 In this scenario, the disease, through its symptoms, affects the medication and not vice-versa and 
thus the underlying causal mechanism is different from that of confounding (Fig. 4). It is of interest that this potential 
confusion between confounding by indication and reverse causation is less likely to occur when the exposure of interest is 
the maternal treatment in pregnancy, as in Fig. 3b: the indication for maternal treatment depends on maternal factors, and 
early manifestations of the child outcome cannot precede the exposure and introduce bias through reverse causation.  
Treatments are prescribed with the intended aim of changing the natural history of a disease and prevent unfavorable 
outcomes (e.g., patients with respiratory infectious diseases are prescribed antibiotics to prevent death).6 Treatments 
prescribed in a clinically appropriate manner are thus used more frequently by individuals with a high risk of having the 
outcome. For this reason, con-founding by indication is particularly challenging, that is, the indication is strongly 
associated with both the treatment and the outcome. When it comes to side effects of the treatment, or the so-called 
unintended effects, especially when they are unknown or occur in the long term, the association between the indication 
and the outcome is expected to be weaker as the treatment is not prescribed specifically to prevent that outcome.6 Let us 
consider an example of intended and unintended effects of use of antibiotics in pregnancy. Genitourinary infections in 
pregnancy are a strong indication for use of antibiotics and are strongly associated with the risk of adverse birth outcomes 
among the untreated women. An observational study on the use of antibiotics in pregnancy and adverse birth outcomes 
could find a positive association due to confounding by indication. In a study of use of antibiotics in pregnancy and child 
obesity, genitourinary infections would still be a strong indication for use of antibiotics, but their association with the 
outcome of interest (child obesity) among the untreated women would be much weaker. Confounding by indication could 
still introduce bias, but the magnitude of the bias would be smaller. Thus, confounding by indication is typically less 
problematic when the outcome of interest regards an unintended than an intended effect of the treatment. This has obvious 
positive implications for the validity of birth cohort research, which typically focuses on unintended long-term effects. 
 
Impact of baseline selection on confounding 
 
In birth cohort studies, participants can be either selected according to some prespecified criteria (intentional selection) 
and/or self-selected because of low baseline response rates or recruitment of volunteers (unintentional selection). It is 
widely acknowledged that baseline selection might alter the confounding pattern present in the general population,16–20 but 
there is still lack of clarity on the potential underlying mechanisms and on the consequences in terms of validity of the 
study results.  
Baseline selection in birth cohorts, as well as in any cohort study, by definition cannot be affected by the outcome of 
interest. In this context, the confounding pattern of the general population can be altered if both the exposure of interest 
and another risk factor for the outcome are associated – either directly or through some other variables – with the 
probability of selection into the study. Some potential scenarios are illustrated in Fig. 5, where E indicates the exposure of 
interest, R a risk factor for the outcome Y, S an indicator of selection into the cohort and U is another unmeasured 
variable. Clearly modified/alternative versions of scenarios depicted in Fig. 5 exist and these scenarios are not mutually 
exclusive. Moreover, in the graphs for simplicity, we focus only on unintentional selection, but the same line of rea-
soning can be applied to the other selection mechanism.  
In the first situation (Fig. 5a), the exposure and the risk factor are associated in the general population because they share 
a common cause U and both affect the probability of being a volunteer. As a consequence, R is a confounder of the E–Y 
rela-tionship, but among the study subjects, the E–R association is altered due to implicit conditioning on volunteering, 
which in Fig. 5a is a collider. Under this mechanism, baseline selection can either induce or attenuate the confounding 
effect of R depending on the strength and direction of the relationships involved (E-Volunteering, R-Volunteering, U–E, 
U–R).21,22 An example of such scenario could be a study that aims to evaluate the effect of maternal consumption of 
antidepressant during pregnancy (E) on child neurodevelopment (Y), where both consumption of anti-depressant and 
smoking during pregnancy (R) – a risk factor for the outcome of interest – are likely to decrease the probability of 
volunteering into the study. In the general population, we can assume that these two variables are positively associated 
due to the inverse association of maternal education (U) with both maternal consumption of antidepressant and smoking 
during pregnancy and therefore we can assume that positive confounding is present. As both smoking and consumption of 
antidepressant affect baseline selection in the same direction, we expect that among study participants a spurious negative 
asso-ciation is induced between these two variables, thus attenuating the confounding present in the general population. 
An example with the same underlying mechanisms but with enlarged con-founding bias due to baseline selection might 
be a study where parity (E) and smoking (R) negatively affect participation and are negatively associated in the general 
population due to maternal age (U), which is positively associated with parity and negatively with smoking during 
pregnancy.  
In the second situation (Fig. 5b), the exposure and the risk factor still affect the likelihood of being a volunteer but are 
now independent in the general population. Restricting on S induces an association between E and R, making R a 
confounder among the study subjects. This is a type of collider bias that has been described extensively in the 
epidemiological literature5,16–18,21,22 and that has been quantified also by simulation studies.21 An example of such scenario 
might be a study in which we want to evaluate the effect of maternal education (E) on reproductive outcomes (Y), where 
both maternal education and occurrence of previous miscarriages (R) affect the probability of participating into the study 
(S). Assuming that these two variables are inde-pendent in the time and place in which the study is conducted, when 
analyzing the birth cohort data, previous miscarriages become a confounder for the association between maternal edu-
cation and reproductive outcomes. 
 
Another special and relevant case is the one depicted in Fig. 5c, where the risk factor R is a confounder in the general 
population because it shares the common cause U with the exposure of interest E and the common cause is the factor 
influencing volunteering. Under this scenario, although there might be exceptions,23 typically the confounding bias 
present in the general population due to the E–U–R–Y backdoor path would be attenuated in the selected cohort because 
conditioning on S would imply a partial con-ditioning on U. This might be the case of a study on the effect of alcohol 
consumption during pregnancy (E) on child neurodeve-lopment (Y) with maternal education (U) influencing participation 
as well as alcohol consumption and maternal pre-pregnancy body mass index (BMI) (R), which we assume not to affect 
volunteering.  
In all these scenarios, both in the general population and in the selected cohort, conditioning on R would block the 
backdoor path from E to Y and enhance valid scientific inference for the expo-sure–outcome effect. When R is unknown 
or unmeasured, con-founding might be present both in the general population and in the selected birth cohort or in only 
one of the two depending on the underlying mechanisms involved, as baseline selection might induce but also reduce the 
confounding present in the general population. The bottom line is that the confounding pattern in the birth cohort may 
differ from that of the corresponding general population, both in terms of amount and direction of bias and in terms of 
relevant variables, we need to control for to minimize confounding, and efforts should be made to collect information on 
all known or potential relevant risk factors for the outcome of interest. 
 
Time-varying confounding 
 
If the aim of a study is to estimate the causal effect of a time-varying exposure, that is, measured at different times for 
each subject, on an outcome, it is likely that time-varying confounders are present, that is, factors which change over time 
and confound the time-varying exposure–outcome causal relationship. The time-varying confounder affects the future 
exposure and predicts the outcome conditional on the past exposure. A simplified sce-nario with measured time-varying 
confounders and without further unmeasured and/or time-fixed confounders is represented in Fig. 6. The time-varying 
exposure is indicated by Et, t = 0 , … , T, the time-varying confounder is indicated by Lt, t = 0, … , T, with Lt occurring 
immediately before Et, and Y is the outcome of interest measured at a later time t > T. Let Et, t = 0, 3, 6, 12, represents the 
breastfeeding measured at 24 h after birth, 3, 6 and 12 months, Lt, t = 0, 3, 6, 12, the infant’s weight at the same times and 
Y the infant’s wheezing at 18 months. Here, the infant’s weight can affect the current breastfeeding status and, at the 
same time, may be affected by the infant’s earlier breastfeeding status. Infant’s weight is both a confounder and a 
mediator of the rela-tionship between breastfeeding and the risk of infant’s wheezing. In this framework, traditional 
modeling strategies cannot be used. Controlling only for infant’s weight measured at baseline (L0) would produce a biased 
estimate of the causal effect of breast-feeding (Et, t = 0, 3, 6, 12) on the risk of wheezing (Y) because it would ignore the 
fact that the breastfeeding over the first year of life (Et, t = 3, 6, 12) depends on infants’ weight (Lt, t = 3, 6, 12), which, in 
turn, affects the risk of wheezing independently from breastfeeding. However, also controlling for time-varying mea-
surements of infant’s weight (Lt, t = 0, 3, 6, 12) affected by prior breastfeeding would give a biased estimate of the causal 
effect of interest because breastfeeding (Et, t = 0, 3, 6, 12) acts partly through the effect of infant’s weight (Lt, t = 3, 6, 12) 
on the outcome (Y).24 Furthermore, in the presence of an unmeasured confounder of the time-varying confounders and the 
outcome association, controlling for time-varying measurements of the exposure would introduce a further source of 
collider bias5 due to the induced spurious association between the exposure and the unmeasured confounder and 
consequently between the exposure and the outcome. Hence, there is the need for using alternative methods based on 
counterfactuals,25,26 such as inverse probability weighting,26–28 G-formula computation26,29,30 and g-estima-tion,26,29,31 that 
adjust for confounding without blocking the effect of the exposure on the confounder. 
 
Mediator–outcome confounding 
 
Mediation analyses are traditionally performed by regressing the outcome on the exposure with and without the 
mediator.32 One common example is the adjustment for gestational age or weight at birth in studies aiming to assess the 
effect of maternal prenatal exposures on offspring outcomes. The estimate is interpreted as a total effect of the exposure 
on the outcome in the model unad-justed for the mediator and as a direct effect in the model adjusted for the mediator 
(i.e., the effect that is not mediated by the mediator included in the model). The difference between total and direct effects 
is the indirect effect (i.e., the effect that acts through the mediator included in the model). This traditional approach to 
mediation analyses may produce flawed conclusions due to four main sources of potential bias: (i) misclassification of the 
mediator,33–36 (ii) the presence of exposure–mediator or exposure–confounders interaction and non-linearities,37 (iii) 
collider bias5,38 might occur when adjusting for a mediator in the presence of unmeasured mediator–outcome 
confounding37 and a direct effect cannot be estimated if a variable that lies on the direct path between the exposure and 
the outcome confounds the mediator–outcome effect.37 Mediation approaches using coun-terfactual theory to estimate 
controlled and natural effects and approaches to sensitivity analyses have been developed, which address some of these 
limitations. These methods are beyond the scope of this review and have already been described else-where.37,39 Here, we 
will discuss further the issue of mediator–outcome confounding and the special case when mediator–out-come 
confounding is affected by the exposure.  
Suppose that we are interested in estimating the causal effect of an exposure on the outcome for a given level of the 
mediator (the controlled direct effect).37,40,41 In this context, not only we need to assume no unmeasured confounding of 
the exposure–outcome association but also we should assume absence of unmeasured confounding of the mediator–
outcome association. We indicate the exposure by E, the mediator by M, the outcome by Y, the set of measured 
confounders of the E–Y association by C1 and the unmeasured confounder of the M–Y association by U (Fig. 7a). An 
example of this scenario could be maternal BMI (E), breast-feeding duration (>6 months v. 6 months) (M) and obesity at 
school age (Y), where U indicates the occurrence of infant’s infections in the first 6 months of life. The question of 
interest is how much of the effect of maternal BMI on the obesity at school age is mediated by breastfeeding duration, or 
in other words, the question is what would be the remaining effect of maternal BMI on the obesity at school age if all 
women breastfed for at least 6 months. As previously described, a common approach to address this question is to 
condition on breastfeeding duration (M), by stratifying the analyses on it or controlling for it in a regression model. 
However, conditioning on breastfeeding dura-tion (a collider) (M) would induce a spurious association between maternal 
BMI (E) and occurrence of infant’s infections in the first 6 months of life (U),42,43 opening the backdoor path maternal 
BMI–infant’s infections–obesity (E–U–Y), thus inducing a bias in the effect of interest. Hence, when estimating the 
controlled direct effect of an exposure on an outcome, traditional multivariable methods can be used if all confounders of 
mediator–outcome association are measured and are included in the analyses. Sen-sitivity analyses have been proposed44 
in order to quantify the bias in the presence of unmeasured/unknown mediator–outcome confounders. Suppose now that 
measured M–Y confounders (C2) are affected by E (Fig. 7b), in which C2 could be infant’s growth. Controlling for 
infant’s growth (C2) to account for the spurious association induced by conditioning on breastfeeding (M) would give a 
biased estimate of the controlled direct effect because, in this way, the path from maternal BMI (E) to obesity at school 
age (Y) that goes through infant’s growth (C2) would be blocked. In these circumstances, controlled direct effects can be 
consistently esti-mated using alternative methods based on counterfactuals, such as the inverse probability weighting27,28 
and the G-formula compu-tation,29,30,45 that adjust for the effect of confounder on the M-Y association but not for the 
effect of exposure on the confounder. Further assumptions on absence of unmeasured/measured con-founders are required 
when the aim is to estimate natural direct and indirect effects in a mediation analysis.40,41 
 
 
Discussion 
 
In this study, we described and discussed sources of confounding in birth cohort studies, provided some examples and 
referred to the methods that have been developed to tackle them. In most instances, multiple sources of confounding 
coexist, and each study has its specific confounding pattern. It is easy to conclude that confounding is one of the main 
challenges to causal inference in life course epi-demiology. It is particularly relevant in the context of individual 
participant data meta-analyses of birth cohort studies.3 Individual participant data meta-analyses on environmental 
exposures and genetic associations have already been published as part of birth cohort collaborations, such as CHICOS 
(http://www.chicosproject. eu/the-project/management/), EGG (http://egg-consortium.org/) and ENRIECO 
(http://www.enrieco.org/). These meta-analyses are commonly undertaken using the same set of confounders among all 
participating cohorts. This might be problematic if potential different confounding patterns, caused by different 
confounding structures in the population and/or baseline selection, are present. However, considering cohort-specific sets 
of covariates might be particularly difficult and time-consuming in an individual participant data meta-analysis 
comprising several cohorts. Also, adjustment for different covariates would complicate the use of one-stage models (i.e., 
indi-vidual level data from all studies are simultaneously analyzed in a multilevel model, taking into account clustering of 
participants within studies), limiting the analyses to two-stage models (i.e., individual-level data within a study are 
analyzed and subsequently, the results from each study are combined using conventional meta-analytical methods). 
Although both approaches can suffer from estimation challenges, the use of one-stage methods has been recommended.46 
Measures of heterogeneity and inconsistency across studies in a meta-analysis have been developed,47 and although a low 
value can support at least partly a little influence of confounding on the results, a high value is not necessarily indicative 
of different confounding patterns. Bias related to confounding might be indir-ectly evaluated by subgroup analyses of 
individual participant data (for instance, data from middle-income and high-income cohorts may be analyzed separately). 
Two-stage models considering a spe-cific set of covariates per cohort might also be performed. Further research should 
focus on the impact of cohort-specific confounding in individual participant data meta-analyses. 
 
Acknowledgments. None. 
 
Financial support. This work was supported by the European Union’s Horizon 2020 research and innovation program 
under grant agreement 733206 (LifeCycle Project). 
 
Conflicts of interest. None. 
 
References 
 
1. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Community Health. 2003; 57, 
778–783.  
2. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and 
interdisci-plinary perspectives. Int J Epidemiol. 2002; 31, 285–293.  
3. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 
2010; 340, c221. 
4. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edn, 2008. Lippincott Williams & Wilkins: Philadelphia, PA.  
5. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003; 
14, 300–306.  
6. Miettinen OS. The need for randomization in the study of intended effects. Stat Med. 1983; 2, 267–271.  
7. Strom BL. Pharmacoepidemiology, 3rd edn, 2000. Wiley: New York, NY.  
8. Joseph KS, Mehrabadi A, Lisonkova S. Confounding by indication and related concepts. Curr Epidemiol Rep. 2014; 1, 1–8.  
9. van Meel ER, den Dekker HT, Elbert NJ, et al. A population-based prospective cohort study examining the influence of early-
life respiratory tract infections on school-age lung function and asthma. Thorax. 2018; 73, 167–173.  
10. McMahon AD. Approaches to combat with confounding by indication in observational studies of intended drug effects. 
Pharmacoepidemiol Drug Saf. 2003; 12, 551–558.  
11. Garbe E, Suissa S. Pharmacoepidemiology. In Handbook of Epidemiology (eds. Ahrens W, Pigeot I), 2nd edn, 2014; pp. 1875–
1925. Springer: New York. 
12. Popovic M, Rusconi F, Zugna D, et al. Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study. Eur 
Respir J. 2016; 47, 810–817.  
13. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 
2014; 370, 2397–2407. 
14. Horwitz RI, Feinstein AR. The problem of ‘protopathic bias’ in case-control studies. Am J Med. 1980; 68, 255–258.  
15. Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. 
Am J Epidemiol. 1999; 149, 981–983.  
16. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004; 15, 615–625.  
17. Pizzi C, De Stavola BL, Pearce N, et al. Selection bias and patterns of confounding in cohort studies: the case of the NINFEA 
web-based birth cohort. J Epidemiol Community Health. 2012; 66, 976–981.  
18. Richiardi L, Pizzi C, Pearce N. Commentary: representativeness is usually not necessary and often should be avoided. Int J 
Epidemiol. 2013; 42, 1018–1022.  
19. Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol. 2013; 42, 1012–1014.  
20. Keiding N, Louis TA. Perils and potentials of self-selected entry to epidemiological studies and surveys. J R Statist Soc A. 
2016; 179, 319–376. 
21. Pizzi C, De Stavola B, Merletti F, et al. Sample selection and validity of exposure-disease association estimates in cohort 
studies. J Epidemiol Community Health. 2011; 65, 407–411.  
22. Glymour MM. Using causal diagrams to understand common problems in social epidemiology. In Methods in Social 
Epidemiology (ed. Jossey-Bass), 2006. pp. 393–428. Jossey-Bass: San Francisco, CA.  
23. Ogburn EL, VanderWeele TJ. On the nondifferential misclassification of a binary confounder. Epidemiology 2012; 23, 433–
439.  
24. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 
2009; 20, 488–495. 
25. Hernán MA, Robins JM. Causal Inference. 2017. Chapman & Hall/CRC: Boca Raton, FL.  
26. Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JA. Methods for dealing with time-dependent confounding. 
Stat Med. 2013; 32, 1584–1618.  
27. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of 
HIV-positive men. Epidemiology. 2000; 11, 561–570.  
28. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000; 
11, 550–560.  
29. Naimi AI, Cole SR, Kennedy EH. An introduction to g methods. Int J Epidemiol. 2017; 46, 756–762.  
30. Taubman SL, Robins JM, Mittleman MA, Hernan MA. Intervening on risk factors for coronary heart disease: an application of 
the parametric g-formula. Int J Epidemiol. 2009; 38, 1599–1611.  
31. Hernan MA, Cole SR, Margolick J, Cohen M, Robins JM. Structural accelerated failure time models for survival analysis in 
studies with time-varying treatments. Pharmacoepidemiol Drug Saf. 2005; 14, 477–491.  
32. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and 
statistical considerations. J Pers Soc Psychol. 1986; 51, 1173–1182.  
33. Blakely T, McKenzie S, Carter K. Misclassification of the mediator matters when estimating indirect effects. J Epidemiol 
Community Health. 2013; 67, 458–466.  
34. Valeri L, Vanderweele TJ. The estimation of direct and indirect causal effects in the presence of misclassified binary mediator. 
Biostatistics. 2014; 15, 498–512.  
35. VanderWeele TJ, Valeri L, Ogburn EL. The role of measurement error and misclassification in mediation analysis: mediation 
and measurement error. Epidemiology. 2012; 23, 561–564.  
36. Ogburn EL, VanderWeele TJ. Analytic results on the bias due to nondifferential misclassification of a binary mediator. Am J 
Epidemiol. 2012; 176, 555–561.  
37. Richiardi L, Bellocco R, Zugna D. Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol. 
2013; 42, 1511–1519.  
38. Cole SR, Platt RW, Schisterman EF, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010; 39, 417–
420.  
39. VanderWeele TJ (ed.). Sensitivity analysis for mediation. In Explanation in Causal Inference: Methods for Mediation and 
Interaction, 2015; pp. 66– 97. Oxford University Press: New York.  
40. Petersen ML, Sinisi SE, van der Laan MJ. Estimation of direct causal effects. Epidemiology. 2006; 17, 276–284. 
41. Pearl J. Direct and indirect effects. Seventeenth Conference of Uncertainty in Artificial Intelligence, 2001. Morgan Kaufmann: 
San Francisco, CA. 
42. Hernandez-Diaz S, Schisterman EF, Hernan MA. The birth weight “paradox” uncovered? Am J Epidemiol. 2006; 164, 1115–
1120.  
43. VanderWeele TJ, Mumford SL, Schisterman EF. Conditioning on intermediates in perinatal epidemiology. Epidemiology. 
2012; 23, 1–9.  
44. VanderWeele TJ. Bias formulas for sensitivity analysis for direct and indirect effects. Epidemiology. 2010; 21, 540–551. 
45. Daniel RM, De Stavola B. gformula: Estimating causal effects in the presence of time-varying confounding or mediation using 
the g-computa-tion formula. STATA J. 2011; 11, 479–517. 
46. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD. Individual participant data meta-analysis for a binary 
outcome: one-stage or two-stage? PLoS One. 2013; 8, e60650. 
47. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring incon-sistency in meta-analyses. BMJ. 2003; 327, 557–560. 
 
